• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

First U.S. H1N1 vaccines will be nasal spray

Treyfish

Moderator
Friday, 18th September 2009 - 18:59CET


The first roll-out of vaccines against the new swine flu virus will be 3.4 million doses of MedImmune's needle-free nose spray, the U.S. Centers for Disease Control and Prevention said on Friday.
The CDC's Dr Jay Butler said the vaccines would be distributed the first week of October.
"Initially we anticipate that 3.4 million doses of vaccine will be available," Butler told a telephone briefing. "We estimate that the amount of vaccine that will be available will increase through October."
He said eventually delivery would rise to about 20 million doses a week.
The United States has ordered 195 million doses of H1N1 swine flu vaccine from five companies -- MedImmune, a unit of AstraZeneca, Sanofi-Aventis, Australia's CSL, GlaxoSmithKline and Novartis.:tiphat:http://www.timesofmalta.com/article...s/first-u-s-h1n1-vaccines-will-be-nasal-spray
 
Back
Top Bottom